Hepatic encephalopathy differential diagnosis: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
Line 16: Line 16:
==Differentiating X from other Diseases==
==Differentiating X from other Diseases==
*Hepatic encephalopathy must be differentiated from other diseases that cause [[personality changes]], altered level of [[consciousness]] and [[jerking]] movement of the [[limbs]]([[asterixis]]) such as, complicated [[alcohol withdrawal]], [[Wernicke's encephalopathy|Wernicke encephalopathy]], [[alcohol intoxication]], [[Metabolic diseases|metabolic abnormalities]]([[hypoglycemia]], [[Electrolyte disturbance|electrolyte imbalance]], [[hypercarbia]], and [[uremia]]) ,toxic [[encephalopathy]] from drugs([[sedative]], [[Salicylic acid|salicylates]], [[antidepressants]] and [[antipsychotic drugs]]), altered [[intracranial pressure]](intra[[cranial]] [[Tumor|tumors]], ,[[subdural hematoma]], [[Intracranial hemorrhage|intracranial bleeding]] and [[Intracranial abscess|abscesses]]), [[intoxication]] by chemical agents, [[malnutrition]], [[hypoxia]] of brain, and sever intra[[Cranial|crania]]<nowiki/>l or systemic [[Infection|infections]]([[meningitis]] and [[encephalitis]]).
*Hepatic encephalopathy must be differentiated from other diseases that cause [[personality changes]], altered level of [[consciousness]] and [[jerking]] movement of the [[limbs]]([[asterixis]]) such as, complicated [[alcohol withdrawal]], [[Wernicke's encephalopathy|Wernicke encephalopathy]], [[alcohol intoxication]], [[Metabolic diseases|metabolic abnormalities]]([[hypoglycemia]], [[Electrolyte disturbance|electrolyte imbalance]], [[hypercarbia]], and [[uremia]]) ,toxic [[encephalopathy]] from drugs([[sedative]], [[Salicylic acid|salicylates]], [[antidepressants]] and [[antipsychotic drugs]]), altered [[intracranial pressure]](intra[[cranial]] [[Tumor|tumors]], ,[[subdural hematoma]], [[Intracranial hemorrhage|intracranial bleeding]] and [[Intracranial abscess|abscesses]]), [[intoxication]] by chemical agents, [[malnutrition]], [[hypoxia]] of brain, and sever intra[[Cranial|crania]]<nowiki/>l or systemic [[Infection|infections]]([[meningitis]] and [[encephalitis]]).
{|
{|
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
Line 54: Line 55:
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |-/+
| style="background: #F5F5F5; padding: 5px;" | -/+
| style="background: #F5F5F5; padding: 5px;" |-/+
| style="background: #F5F5F5; padding: 5px;" | -/+
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Alcohol withdrawal
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Alcohol withdrawal
Line 66: Line 67:
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |-/+
| style="background: #F5F5F5; padding: 5px;" | -/+
| style="background: #F5F5F5; padding: 5px;" |-/+
| style="background: #F5F5F5; padding: 5px;" | -/+
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Uremia
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Uremia
Line 78: Line 79:
| style="background: #F5F5F5; padding: 5px;" | -/+
| style="background: #F5F5F5; padding: 5px;" | -/+
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |++
| style="background: #F5F5F5; padding: 5px;" | ++
| style="background: #F5F5F5; padding: 5px;" |Hyperkalemia
| style="background: #F5F5F5; padding: 5px;" |Hyperkalemia
|-
|-
Line 90: Line 91:
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | ++
| style="background: #F5F5F5; padding: 5px;" | ++
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Toxic encephalopathy from drugs
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Toxic encephalopathy from drugs
Line 102: Line 103:
| style="background: #F5F5F5; padding: 5px;" | -/+
| style="background: #F5F5F5; padding: 5px;" | -/+
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |+
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |-/+
| style="background: #F5F5F5; padding: 5px;" | -/+
| style="background: #F5F5F5; padding: 5px;" |-/+
| style="background: #F5F5F5; padding: 5px;" | -/+
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Altered intracranial pressure
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Altered intracranial pressure
Line 114: Line 115:
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -/+
| style="background: #F5F5F5; padding: 5px;" | -/+
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Intoxication by chemical agents
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Intoxication by chemical agents
Line 126: Line 127:
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |-/+
| style="background: #F5F5F5; padding: 5px;" | -/+
| style="background: #F5F5F5; padding: 5px;" |-/+
| style="background: #F5F5F5; padding: 5px;" | -/+
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Malnutrition
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Malnutrition
Line 138: Line 139:
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -/+
| style="background: #F5F5F5; padding: 5px;" | -/+
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |-/+
| style="background: #F5F5F5; padding: 5px;" | -/+
| style="background: #F5F5F5; padding: 5px;" |-/+
| style="background: #F5F5F5; padding: 5px;" | -/+
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hypoxia of brain
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hypoxia of brain
Line 150: Line 151:
| style="background: #F5F5F5; padding: 5px;" | -/+
| style="background: #F5F5F5; padding: 5px;" | -/+
| style="background: #F5F5F5; padding: 5px;" | -/+
| style="background: #F5F5F5; padding: 5px;" | -/+
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Meningitis and encephalitis
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Meningitis and encephalitis
Line 162: Line 163:
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |-/+
| style="background: #F5F5F5; padding: 5px;" | -/+
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hypoglycemia
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hypoglycemia
Line 174: Line 175:
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |-/+
| style="background: #F5F5F5; padding: 5px;" | -/+
| style="background: #F5F5F5; padding: 5px;" |-/+
| style="background: #F5F5F5; padding: 5px;" | -/+
|}
|}


Revision as of 17:20, 18 December 2017

Hepatic encephalopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hepatic Encephalopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hepatic encephalopathy differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatic encephalopathy differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatic encephalopathy differential diagnosis

CDC on Hepatic encephalopathy differential diagnosis

Hepatic encephalopathy differential diagnosis in the news

Blogs on Hepatic encephalopathy differential diagnosis

Directions to Hospitals Treating Hepatic encephalopathy

Risk calculators and risk factors for Hepatic encephalopathy differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:

Overview

jjj

Differentiating X from other Diseases

Diseases History and Symptoms Physical Examination Laboratory Findings
Personality changes Altered level of consciousness Jerking movement of the limbs(asterixis) Slurred speech Writing disturbances Voice monotonous Impaired memory Elevated blood ammonia Hyponatremia hypokalemia
Hepatic encephalopathy ++ ++ ++ ++ ++ ++ ++ ++ ++ ++
alcohol intoxication + + -/+ ++ + - + - -/+ -/+
Alcohol withdrawal + + - ++ + - + - -/+ -/+
Uremia ++ ++ + -/+ -/+ -/+ - ++ Hyperkalemia
Wernicke encephalopathy + + -/+ + + + ++ - - -
Toxic encephalopathy from drugs + + -/+ -/+ + -/+ + + -/+ -/+
Altered intracranial pressure + -/+ - -/+ -/+ - -/+ - - -
Intoxication by chemical agents -/+ -/+ -/+ -/+ -/+ - - - -/+ -/+
Malnutrition -/+ - - - -/+ - -/+ - -/+ -/+
Hypoxia of brain - -/+ - -/+ -/+ -/+ -/+ - - -
Meningitis and encephalitis -/+ -/+ - -/+ + - - - -/+ -
Hypoglycemia -/+ -/+ - -/+ -/+ - - - -/+ -/+

References

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Hepatic_encephalopathy_differential_diagnosis&oldid=1409061"